Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
February 18, 2022ASH 2021: highlights in CLL clinical trials19 minutesPlayTreatments such as ibrutinib and venetoclax, which target the Bruton tyrosine kinase (BTK) pathway and the B-cell lymphoma 2 (BCL-2)......moreShareView all episodesBy VJHemOnc4.522 ratingsFebruary 18, 2022ASH 2021: highlights in CLL clinical trials19 minutesPlayTreatments such as ibrutinib and venetoclax, which target the Bruton tyrosine kinase (BTK) pathway and the B-cell lymphoma 2 (BCL-2)......moreMore shows like VJHemOnc PodcastView allHematologic Oncology Update76 ListenersMayo Clinic Talks288 ListenersThe Curbsiders Internal Medicine Podcast3,337 ListenersBlood Podcast53 ListenersCCO Oncology Podcast9 ListenersBlood Cancer Talks49 ListenersTwo Onc Docs185 ListenersAll Things Amyloid5 ListenersThe Hematology Podcast Series!0 Listeners
Treatments such as ibrutinib and venetoclax, which target the Bruton tyrosine kinase (BTK) pathway and the B-cell lymphoma 2 (BCL-2)...
February 18, 2022ASH 2021: highlights in CLL clinical trials19 minutesPlayTreatments such as ibrutinib and venetoclax, which target the Bruton tyrosine kinase (BTK) pathway and the B-cell lymphoma 2 (BCL-2)......more
Treatments such as ibrutinib and venetoclax, which target the Bruton tyrosine kinase (BTK) pathway and the B-cell lymphoma 2 (BCL-2)...